• Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

ChemoMetec A/S afholder telefonkonference den 11. september 2026 kl. 15.00 til præsentation af den kommende årsrapport for 2025/26

CHEMMPress release07.08.2026, 15.04

ChemoMetec A/S offentliggør årsrapporten for regnskabsåret 2025/26 torsdag den 10. september 2026.

I den forbindelse afholder ChemoMetec A/S telefonkonference fredag den 11. september 2026 kl. 15.00, hvor CEO Martin Helbo Behrens og CFO Phillip Massie Price vil præsentere årsrapporten og besvare spørgsmål.

Konferencen afholdes på engelsk.

Tilmelding sker via dette link.



Yderligere oplysninger

Martin Helbo Behrens, CEO
Telefon: (+45) 81 10 06 80

Phillip Massie Price, CFO
Telefon: (+45) 81 10 06 80


Om ChemoMetec A/S
ChemoMetec udvikler, producerer og markedsfører instrumenter til celletælling og en lang række andre målinger. ChemoMetecs instrumenter markedsføres globalt inden for blandt andet farma, biotek og landbrug. ChemoMetec har nogle af verdens førende medicinalvirksomheder blandt sine kunder.

ChemoMetec blev etableret i 1997 og er børsnoteret på Nasdaq Copenhagen. Se også www.chemometec.com